Hikma Pharmaceuticals (HIK)

Sector:

Pharma and Biotech

Index:

FTSE 100

1,965.00p
   
  • Change Today:
      7.00p
  • 52 Week High: 2,205.00
  • 52 Week Low: 1,722.00
  • Currency: UK Pounds
  • Shares Issued: 221.89m
  • Volume: 18,833
  • Market Cap: £4,360.05m
  • RiskGrade: 125

Latest ShareCast News

Hikma boosts injectables business with Xellia assets acquisition

By Michele Maatouk

Date: Monday 17 Jun 2024

(Sharecast News) - Hikma Pharmaceuticals said on Monday that it has agreed to buy parts of Xellia Pharmaceuticals, a Copenhagen-based specialty company focusing on providing anti-infective treatments and other critical care therapies, for up to $185m.

Citi hikes Hikma price target, cites 'healthy trends' for injectables and US Generics

By Michele Maatouk

Date: Tuesday 11 Jun 2024

(Sharecast News) - Citi lifted its price target on Hikma Pharmaceuticals on Tuesday to 2,845p from 2,770p as it said IQVIA April data highlighted "healthy trends" for injectables and US Generics.

London close: Stocks finish mixed as US GDP growth slows

By Josh White

Date: Thursday 25 Apr 2024

(Sharecast News) - London's stock markets finished with a mixed performance on Thursday, as investors digested a slower-than-expected GDP growth reading from the United States, while a slew of well-received earnings underpinned the top-flight index.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

HIK Market Data

Currency UK Pounds
Share Price 1,965.00p
Change Today 7.00p
% Change 0.36 %
52 Week High 2,205.00
52 Week Low 1,722.00
Volume 18,833
Shares Issued 221.89m
Market Cap £4,360.05m
RiskGrade 125

HIK Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
51.18% below the market average51.18% below the market average51.18% below the market average51.18% below the market average51.18% below the market average
21.57% below the sector average21.57% below the sector average21.57% below the sector average21.57% below the sector average21.57% below the sector average
Price Trend
56.56% above the market average56.56% above the market average56.56% above the market average56.56% above the market average56.56% above the market average
69.81% above the sector average69.81% above the sector average69.81% above the sector average69.81% above the sector average69.81% above the sector average
Income
8.95% above the market average8.95% above the market average8.95% above the market average8.95% above the market average8.95% above the market average
14.29% above the sector average14.29% above the sector average14.29% above the sector average14.29% above the sector average14.29% above the sector average
Growth
36.86% below the market average36.86% below the market average36.86% below the market average36.86% below the market average36.86% below the market average
42.86% below the sector average42.86% below the sector average42.86% below the sector average42.86% below the sector average42.86% below the sector average

What The Brokers Say

Strong Buy 4
Buy 2
Neutral 4
Sell 1
Strong Sell 0
Total 11
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

HIK Dividends

  Latest Previous
  Final Interim
Ex-Div 21-Mar-24 10-Aug-23
Paid 03-May-24 15-Sep-23
Amount 47.00¢ 25.00¢

Trades for 17-Jun-2024

Time Volume / Share Price
10:49 1,000 @ 1,965.82p
10:49 20 @ 1,965.00p
10:46 118 @ 1,965.00p
10:46 43 @ 1,965.00p
10:46 137 @ 1,964.00p

HIK Key Personnel

CEO Riad Mishlawi

Top of Page